Chinese english Germany Korea

C-(5-Methyl-Imidazo[1,2-A]Pyridin-3-Yl)-Methylamine Dihydrochloride(WX603035)

化学構造式
1951441-16-9
CAS番号.
1951441-16-9
化学名:
别名:
英語名:
C-(5-Methyl-Imidazo[1,2-A]Pyridin-3-Yl)-Methylamine Dihydrochloride(WX603035)
英語别名:
C-(5-METHYL-IMIDAZO[1,2-A]PYRIDIN-3-YL)-METHYLAMINE 2HCL;(5-Methylimidazo[1,2-a]pyridin-3-yl)methanamine dihydrochloride;C-(5-Methyl-Imidazo[1,2-A]Pyridin-3-Yl)-Methylamine Dihydrochloride;C-(5-Methyl-Imidazo[1,2-A]Pyridin-3-Yl)-Methylamine Dihydrochloride(WX603035)
CBNumber:
CB33543796
化学式:
C9H12ClN3
分子量:
197.67
MOL File:
1951441-16-9.mol

C-(5-Methyl-Imidazo[1,2-A]Pyridin-3-Yl)-Methylamine Dihydrochloride(WX603035) 物理性質

安全性情報

C-(5-Methyl-Imidazo[1,2-A]Pyridin-3-Yl)-Methylamine Dihydrochloride(WX603035) 価格 もっと(2)

メーカー 製品番号 製品説明 CAS番号 包装 価格 更新時間 購入
富士フイルム和光純薬株式会社(wako) W01COBQK-2592
C-(5-Methyl-imidazo[1,2-a]pyridin-3-yl)-methylamine dihydrochloride 		1951441-16-9 250mg ￥275000 2024-03-01 購入
富士フイルム和光純薬株式会社(wako) W01COBQK-2592
C-(5-Methyl-imidazo[1,2-a]pyridin-3-yl)-methylamine dihydrochloride 		1951441-16-9 1g ￥695000 2024-03-01 購入

C-(5-Methyl-Imidazo[1,2-A]Pyridin-3-Yl)-Methylamine Dihydrochloride(WX603035) 化学特性,用途語,生産方法

C-(5-Methyl-Imidazo[1,2-A]Pyridin-3-Yl)-Methylamine Dihydrochloride(WX603035) 上流と下流の製品情報

原材料

準備製品

C-(5-Methyl-Imidazo[1,2-A]Pyridin-3-Yl)-Methylamine Dihydrochloride(WX603035) 生産企業

Global( 5)Suppliers
名前 電話番号 電子メール 国籍 製品カタログ 優位度
Wuxi AppTec 022-59987777 13552403979
 jia_guoqiang@wuxiapptec.com China 22346 58
Shanghai Kaiwei Chemical Technology Co., Ltd. 021-58461859 15821823057
 service@aiviche.com China 49323 58
Beijing Stronger Science Co., Ltd. 0531-88924771 15614660963
 elsa.hang@strongerscience.com China 10624 58
  • 1951441-16-9
  • C-(5-Methyl-Imidazo[1,2-A]Pyridin-3-Yl)-Methylamine Dihydrochloride(WX603035)
  • C-(5-METHYL-IMIDAZO[1,2-A]PYRIDIN-3-YL)-METHYLAMINE 2HCL
  • C-(5-Methyl-Imidazo[1,2-A]Pyridin-3-Yl)-Methylamine Dihydrochloride
  • (5-Methylimidazo[1,2-a]pyridin-3-yl)methanamine dihydrochloride
Copyright 2017 © ChemicalBook. All rights reserved